Somewhat Positive Media Coverage Somewhat Unlikely to Affect RTI Surgical (RTIX) Stock Price

Media stories about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. RTI Surgical earned a news sentiment score of 0.00 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.3893961602737 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media headlines that may have effected Accern Sentiment’s rankings:

RTI Surgical (RTIX) traded up $0.10 during trading hours on Thursday, hitting $4.30. 401,800 shares of the stock were exchanged, compared to its average volume of 186,457. The firm has a market capitalization of $255.50, a price-to-earnings ratio of 105.00, a P/E/G ratio of 5.60 and a beta of 1.76. RTI Surgical has a 1 year low of $3.01 and a 1 year high of $6.00. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.01. The firm had revenue of $66.69 million for the quarter, compared to analyst estimates of $65.63 million. RTI Surgical had a net margin of 1.01% and a return on equity of 2.29%. The business’s revenue was up .2% compared to the same quarter last year. equities research analysts forecast that RTI Surgical will post 0.05 EPS for the current fiscal year.

A number of research analysts have issued reports on the stock. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, October 13th. BidaskClub cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Tuesday, December 5th.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect RTI Surgical (RTIX) Stock Price” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit